Clinical Trials Directory

Trials / Completed

CompletedNCT03166514

Glycemic Response of a Commercial Food Bar

Pharmacokinetic and Glycemic Response of a Commercially Available Food Bar

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Texas A&M University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the glucose and insulin response to a food bar.

Detailed description

Fitjoy is a commercially available food bar marketed as having a low glycemic index and being relatively high in dietary fiber. The fiber contained within this product is isomalto-oligoshaccaride (IMO) which is a food ingredient with a relative sweetness level equal to approximately 60% of sucrose. Chemically, IMO is a mixture of glucose oligomers with alpha - (1-6) - linkages. To date, no research has been performed on the glycemic response to ingesting IMO in combination with other constituents. Therefore the purpose of this study is to determine the glycemic index of the Fitjoy bar.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCommercially Available Food Bar
DIETARY_SUPPLEMENTPlacebo

Timeline

Start date
2017-01-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2017-05-25
Last updated
2020-04-13

Source: ClinicalTrials.gov record NCT03166514. Inclusion in this directory is not an endorsement.